Avalo Therapeutics, Inc. (AVTX) Net income 2016–2025
Avalo Therapeutics, Inc. (AVTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$78.3MFY2025 · since FY2016: -$16.5M → -$78.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$78.3M | -122.8% |
| FY2024 | -$35.1M | -11.4% |
| FY2023 | -$31.5M | +24.3% |
| FY2022 | -$41.7M | +50.6% |
| FY2021 | -$84.4M | -32.9% |
| FY2020 | -$63.5M | -295.1% |
| FY2019 | -$16.1M | +59.9% |
| FY2018 | -$40.1M | -437.4% |
| FY2017 | $11.9M | +172.1% |
| FY2016 | -$16.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice